Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Adaptive Biotechnologies a Buy?

TheMotleyFool

0 0

Is Adaptive Biotechnologies a Buy?Photo, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

There's nothing like a viral pandemic to remind investors how important it is to understand the human immune system. Shares of Adaptive Biotechnologies (NASDAQ: ADPT) soared when the biotech took steps to address the coronavirus pandemic and partnered with Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT) in the process.

Earlier this year, an enthusiastic market more than doubled the price of Adaptive Biotechnologies stock. Now that shares are trading around 22% below their recent peak, investors are wondering if it's a good time to buy.

Image source: Getty Images.

Source Fool.com

Like: 0

ADPT

Share